Pharmabiz30m
Innovent Biologics, ASK Pharm announce China’s NMPA approval of limertinib to treat metastatic EGFR T790M-mutated NSCLCr
Innovent Biologics, ASK Pharm announce China’s NMPA approval of limertinib to treat metastatic EGFR T790M-mutated NSCLCr: San Francisco Saturday, January 18, 2025, 09:00 Hrs [IS ...
Pharmabiz1h
FIEO to host power talk ‘SME in Focus’ for SMEs in pharma sector in Hyderabad on January 24
FIEO to host power talk ‘SME in Focus’ for SMEs in pharma sector in Hyderabad on January 24: Shardul Nautiyal, Mumbai Saturday, January 18, 2025, 08:00 Hrs [IST] The Federatio ...
Pharmabiz1h
DGFT issues new SOP for voluntary disclosure of SCOMET violations to bolster India’s pharma export control framework
Shardul Nautiyal, Mumbai Saturday, January 18, 2025, 08:00 Hrs [IST] ...
Pharmabiz1h
Kerala govt creates 250 posts of pharmacists under dept of health & family welfare, appointment to start soon
Kerala govt creates 250 posts of pharmacists under dept of health & family welfare, appointment to start soon: Peethaambaran Kunnathoor, Chennai Saturday, January 18, 2025, 08:00 ...
Pharmabiz1h
NPPA asks manufacturers to submit data on certain dosage forms of nicotine to fix ceiling prices
Gireesh Babu, New Delhi Saturday, January 18, 2025, 08:00 Hrs [IST] ...
Pharmabiz1h
Orthopaedics sector on the cusp of a transformative era driven by technological solutions: Sushant Banerji
Orthopaedics sector on the cusp of a transformative era driven by technological solutions: Sushant Banerji: Shardul Nautiyal, Mumbai Saturday, January 18, 2025, 08:00 Hrs [IST] Th ...
Pharmabiz1h
Indian pharma hopes for policy-level clarifications & simplifying APA procedures in Union Budget 2025
Indian pharma hopes for policy-level clarifications & simplifying APA procedures in Union Budget 2025: Nandita Vijayasimha, Bengaluru Saturday, January 18, 2025, 08:00 Hrs [IST] I ...
Pharmabiz3d
DFE Pharma expands its C2F Center of Excellence in Hyderabad to advance the development of critical respiratory treatments
DFE Pharma, a global leader in pharmaceutical and biopharmaceutical excipient solutions, has expanded the capabilities of its Closer to the Formulator (C2F) Center of Excellence located in Genome ...
Pharmabiz3d
Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced a pilot proteomics programme to analyze 50,000 UK Biobank samples in collaboration with deCODE Genetics, ...
Pharmabiz3d
India initiates anti-dumping probe on Resorcinol imports from China and Japan
The Directorate General of Trade Remedies (DGTR) has issued an updated notification concerning the ongoing anti-dumping investigation into imports of Resorcinol from China PR and Japan. The ...
Pharmabiz3d
PDMA asks govt to create separate category for units below Rs. 10 crore & allow 3 years to implement revised Schedule M
The Punjab Drug Manufacturers Association (PDMA) has sought the Union ministry of health and family welfare to create a separate category for units below Rs. 10 crore turnover outside the erstwhile ...
Pharmabiz3d
China NMPA approves Sanofi’s Sarclisa in combo with pomalidomide and dexamethasone to treat adult patients with R/R multiple myeloma
The National Medical Products Administration (NMPA) in China has approved Sarclisa, an anti-CD38 medicine, in combination with pomalidomide and dexamethasone (Pd) for the treatment of adult patients ...